Find an expert
Our panel of editors and experts are available for interview
Ian Mulvany
Chief Technology Officer, BMJ Group
Since joining BMJ Group in 2020 during the pandemic, Ian has led a sweeping digital transformation, strengthening the organisation’s infrastructure, accelerating its adoption of cloud-based platforms, and embedding AI and automation to improve delivery. Ian has a long track record of driving innovation in research technology. At SAGE Publishing, he founded SAGE Ocean, an incubator advancing new methods for social science research using big data. Earlier roles include Head of Technology at eLife Sciences, Head of Product at Mendeley, and Product Manager at Nature Publishing Group. He has also consistently advocated for open science, serving on the board of Dryad and the editorial board of the Journal of Open Research Software.
A recognised thought leader on digital transformation and AI in publishing, Ian has spoken at The London Book Fair, ALPSP, STM Week, and the International Association of Scientific, Technical and Medical Publishers (STM), as well as in podcasts and webinars on the future of open research, data, and AI adoption.
He regularly shares his reflections on technology, research, and innovation on his personal blog: mulvany.net
.
Professor Bryony Dean Franklin
Editor-in-Chief of BMJ Quality & Safety
Professor Bryony Dean Franklin is a hospital pharmacist by background, with 30 years’ experience of research into medication safety, medication use in practice and patient safety more generally. She is Co-Editor-in-Chief of BMJ Quality & Safety, Professor of Medication Safety at UCL School of Pharmacy, Executive Lead Pharmacist for Research at Imperial College Healthcare NHS Trust, Director of the NIHR North West London Patient Safety Research Collaboration and theme lead for the NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London. Professor Franklin has published widely on medication safety, the evaluation of various technologies designed to reduce errors, and the patient’s role in patient safety. Her current post combines research, quality improvement, education and training, medical publishing and hospital pharmacy practice.
Theodora Bloom
Executive Editor of the BMJ
Theodora Bloom is executive editor of The BMJ. At the BMJ, Theo’s responsibilities include publishing, business, platform and operations as well as ethical and policy matters. She is a Co-Founder of the medRxiv preprint server, a collaboration between BMJ, Cold Spring Harbor Laboratory and Yale University, and jointly coordinates open access and open research initiatives at BMJ.
Professor Ganesan Karthikeyan
Editor-in-Chief Open Heart
Professor Karthikeyan is a clinical, interventional cardiologist and a Senior International Fellow of the Population Health Research Institute at McMaster University in Canada, as well as Professor of Cardiology at AIIMS. His research is mainly focused on cardiovascular diseases affecting low and middle income countries, including valvular heart disease, particularly rheumatic heart disease (RHD), mechanical valve thrombosis, anticoagulation, and indigenous drug-eluting stents.
Dr Andrea Cipriani
Editor-in-Chief of Evidence-Based Mental Health
Andrea Cipriani, MD, PhD, is Professor of Psychiatry and NIHR Research Professor at the University of Oxford. He is an honorary consultant psychiatrist at the Associate Director for Oxford Health NHS Foundation Trust in Oxford. His main research interests are evidence-based mental health and precision psychiatry. His research focuses on the evaluation of pharmacological, psychological and psychosocial interventions.
Professor Juan Víctor Ariel Franco
Editor-in-Chief of BMJ Evidence-Based Medicine
Professor Juan Franco is a family doctor at the Hospital Italiano de Buenos Aires, Argentina, and Vice-chair of the Research Department at the Instituto Universitario Hispital Italiano (IUHI), where he is also Director of the Cochrane Associate Centre. He is a professor at IUHI and Universidad Nacional de La Matanza, and editor for the Cochrane Urology Group and a member of Cochrane’s Governing Board.
